rs1555623867
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_StrongPM2
The NM_002386.4(MC1R):c.698dup(p.Phe235LeufsTer4) variant causes a frameshift change. The variant allele was found at a frequency of 0.000000685 in 1,460,014 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. Q233Q) has been classified as Benign.
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 6.8e-7 ( 0 hom. )
Consequence
MC1R
NM_002386.4 frameshift
NM_002386.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.28
Genes affected
MC1R (HGNC:6929): (melanocortin 1 receptor) This intronless gene encodes the receptor protein for melanocyte-stimulating hormone (MSH). The encoded protein, a seven pass transmembrane G protein coupled receptor, controls melanogenesis. Two types of melanin exist: red pheomelanin and black eumelanin. Gene mutations that lead to a loss in function are associated with increased pheomelanin production, which leads to lighter skin and hair color. Eumelanin is photoprotective but pheomelanin may contribute to UV-induced skin damage by generating free radicals upon UV radiation. Binding of MSH to its receptor activates the receptor and stimulates eumelanin synthesis. This receptor is a major determining factor in sun sensitivity and is a genetic risk factor for melanoma and non-melanoma skin cancer. Over 30 variant alleles have been identified which correlate with skin and hair color, providing evidence that this gene is an important component in determining normal human pigment variation. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.269 CDS is truncated, and there are 1 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MC1R | NM_002386.4 | c.698dup | p.Phe235LeufsTer4 | frameshift_variant | 1/1 | ENST00000555147.2 | NP_002377.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MC1R | ENST00000555147.2 | c.698dup | p.Phe235LeufsTer4 | frameshift_variant | 1/1 | NM_002386.4 | ENSP00000451605 | P1 | ||
ENST00000554623.1 | n.856_857insT | non_coding_transcript_exon_variant | 2/2 | 3 | ||||||
MC1R | ENST00000555427.1 | c.698dup | p.Phe235LeufsTer4 | frameshift_variant | 3/4 | 5 | ENSP00000451760 | |||
MC1R | ENST00000639847.1 | c.698dup | p.Phe235LeufsTer4 | frameshift_variant | 3/3 | 5 | ENSP00000492011 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460014Hom.: 0 Cov.: 35 AF XY: 0.00000138 AC XY: 1AN XY: 726330
GnomAD4 exome
AF:
AC:
1
AN:
1460014
Hom.:
Cov.:
35
AF XY:
AC XY:
1
AN XY:
726330
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Melanoma, cutaneous malignant, susceptibility to, 5 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 18, 2017 | In summary, this is a novel loss-of-function variant in a gene in which other loss-of-function variants have a suggested association with increased melanoma risk. However, the relative disease risk of this variant has not been assessed. Therefore, it has been classified as a Variant of Uncertain Significance. Other loss-of-function missense variants in MC1R have been correlated with lighter skin pigmentation (PMID: 11030758) and possibly increased melanoma risk, although no definitive disease association has been concluded (PMID: 18366057, 21128237). This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with an MC1R-related disease. Experimental studies have not been reported for this truncating variant, and it is currently unknown if the last 83 amino acids of the MC1R protein are critical for its function. This sequence change inserts 1 nucleotide in the single exon of the MC1R mRNA (c.698dupA), causing a frameshift at codon 235. This creates a premature translational stop signal in the MC1R mRNA (p.Phe235Leufs*4). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 83 amino acids of the MC1R protein. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at